← back to search

Sebastián Morán

University of California, Riverside · US
Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include DNA methylation, Biology, Epigenetics, CpG site, Methylation, and Medicine.
h-index
citations
5,623
works
16
NIH funding
primary concept
email

Recent publications

An epigenetic switch controls an alternative NR2F2 isoform that unleashes a metastatic program in melanoma
Nature Communications 2023cited by 24position: middledoi
Sarcoma classification by DNA methylation profiling
Nature Communications 2021cited by 536position: middledoi
Epigenetic loss of RNA-methyltransferase NSUN5 in glioma targets ribosomes to drive a stress adaptive translational program
Acta Neuropathologica 2019cited by 194position: middledoi
<i>SIPA1L3</i> methylation modifies the benefit of smoking cessation on lung adenocarcinoma survival: an epigenomic–smoking interaction analysis
Molecular Oncology 2019cited by 27position: middledoi
Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis
The Lancet Respiratory Medicine 2018cited by 222position: middledoi
DNA methylation-based reclassification of olfactory neuroblastoma
Acta Neuropathologica 2018cited by 75position: middledoi
Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer
Gut 2017cited by 238position: middledoi
Higher prevalence of cerebral white matter hyperintensities in homozygous <i>APOE-ɛ4</i> allele carriers aged 45–75: Results from the ALFA study
Journal of Cerebral Blood Flow & Metabolism 2017cited by 48position: middledoi
DNA methylation signal has a major role in the response of human breast cancer cells to the microenvironment
Oncogenesis 2017cited by 38position: middledoi
A Landscape of Pharmacogenomic Interactions in Cancer
Cell 2016cited by 2,239position: middledoi
Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis
The Lancet Oncology 2016cited by 508position: firstdoi
Epigenomic analysis detects aberrant super-enhancer DNA methylation in human cancer
Genome biology 2016cited by 221position: middledoi
Human DNA methylomes of neurodegenerative diseases show common epigenomic patterns
Translational Psychiatry 2016cited by 166position: middledoi
Epigenetic activation of a cryptic TBC1D16 transcript enhances melanoma progression by targeting EGFR
Nature Medicine 2015cited by 115position: middledoi
Distinct DNA methylomes of newborns and centenarians
Proceedings of the National Academy of Sciences 2012cited by 819position: middledoi
DNA methylation profiling in breast cancer discordant identical twins identifies DOK7 as novel epigenetic biomarker
Carcinogenesis 2012cited by 153position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Manel Esteller · Hospital de Sant Pau7 papers (2012–2023)Holger Heyn · Universitat de Barcelona4 papers (2012–2016)Sergi Sayols · Institute of Molecular Biology4 papers (2012–2016)Antonio Gómez · Universitat de Vic - Universitat Central de Catalunya3 papers (2012–2016)Humberto J. Ferreira · University of Lausanne3 papers (2012–2016) · 3 papers (2012–2016)Marta Gut · Centro Nacional de Análisis Genómico2 papers (2012–2016)Enrique Vidal · European Molecular Biology Laboratory2 papers (2016–2016)Ramón Martínez · Texas Children's Hospital1 papers (2016–2016) · 1 papers (2016–2016) · 1 papers (2012–2012) · 1 papers (2016–2016)Guillaume Devailly · Université Claude Bernard Lyon 11 papers (2017–2017) · 1 papers (2023–2023)Pauline Mathot · Université Claude Bernard Lyon 11 papers (2017–2017)Juan Domingo Gispert · Universitat Pompeu Fabra1 papers (2017–2017)Mario F. Fraga · Universitat de Barcelona1 papers (2012–2012)Gillian Baptiste · Eastern Cooperative Oncology Group1 papers (2023–2023)Mario Campone · Centre de Recherche en Cancérologie de Lyon1 papers (2017–2017)Verónica Dávalos · Josep Carreras Leukaemia Research Institute1 papers (2023–2023)